secwatch.observer — SEC 8-K summary
======================================

Issuer:     Barinthus Biotherapeutics plc. (BRNS)
CIK:        0001828185
Form:       8-K
Filed at:   2026-01-06T23:59:59+00:00
Accession:  0001828185-26-000004
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Barinthus Biotherapeutics receives Nasdaq delinquency notice over bid price below $1.00 per ADR
--------------------------------------------------------------------------------

- On Dec 30, 2025, Nasdaq notified Barinthus that its ADS bid price was below $1.00 for 30 consecutive business days, violating Listing Rule 5450(a)(1).
- Company has 180 calendar days, until June 29, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive business days.
- If not compliant by deadline, a second 180-day period may be available if certain conditions are met; company evaluating options including a reverse stock split.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828185/000182818526000004/0001828185-26-000004-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828185/000182818526000004/brns-20251230.htm
  HTML page:      https://secwatch.observer/filing/0001828185-26-000004

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer